Crucial role of stromal cell-derived factor-1alpha in neointima formation after vascular injury in apolipoprotein E-deficient mice

Circulation. 2003 Nov 18;108(20):2491-7. doi: 10.1161/01.CIR.0000099508.76665.9A. Epub 2003 Oct 27.

Abstract

Background: Recent evidence indicates that stromal cell-derived factor-1alpha (SDF-1alpha) is expressed in human atherosclerotic plaques, whereas high plasma levels are clinically associated with stable coronary artery disease. Herein, we investigate the involvement of SDF-1alpha in neointimal formation after vascular injury.

Methods and results: SDF-1alpha was detected by immunohistochemistry in carotid arteries of apolipoprotein E-deficient (apoE-/-) mice at various stages of neointima formation after wire-induced injury. Double immunofluorescence revealed that SDF-1alpha staining was mostly confined to smooth muscle cells (SMCs). Furthermore, SDF-1alpha plasma levels peaked 1 day after vascular injury. Treatment of apoE-/- mice after carotid injury with a neutralizing SDF-1alpha monoclonal antibody for 3 weeks reduced neointimal lesion area by 44% (n=5, P<0.05) compared with isotype control. In SDF-1alpha antibody-treated apoE-/- mice, neointimal SMC content was decreased (21.7+/-2% versus 39.4+/-4%, n=5, P=0.005), whereas the relative content of neointimal macrophages remained unchanged. As shown by flow cytometry, carotid injury resulted in a marked expansion of circulating Sca-1+lineage- progenitor cells (PBPCs) in the peripheral blood of apoE-/- mice after 1 day, which was mediated by SDF-1alpha. Systemic injection of isolated PBPCs after vascular injury demonstrated their recruitment to neointimal lesions, where they can adopt an SMC-like phenotype.

Conclusions: SDF-1alpha plays an instrumental role in neointimal formation after vascular injury in apoE-/- mice by regulating neointimal SMC content. This contribution appears to be attributable to SDF-1alpha-dependent recruitment of circulating SMC progenitor cells.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Angioplasty / adverse effects
  • Animals
  • Antibodies, Monoclonal / pharmacology
  • Antigens, Ly / biosynthesis
  • Apolipoproteins E / deficiency*
  • Apolipoproteins E / genetics
  • Carotid Arteries / metabolism*
  • Carotid Arteries / pathology
  • Carotid Stenosis / etiology
  • Carotid Stenosis / metabolism*
  • Carotid Stenosis / pathology
  • Carotid Stenosis / therapy
  • Cell Lineage
  • Cell Separation
  • Chemokine CXCL12
  • Chemokines, CXC / antagonists & inhibitors
  • Chemokines, CXC / immunology
  • Chemokines, CXC / metabolism*
  • Disease Progression
  • Female
  • Immunohistochemistry
  • Male
  • Membrane Proteins / biosynthesis
  • Mice
  • Mice, Inbred C57BL
  • Mice, Knockout
  • Muscle, Smooth, Vascular
  • Stem Cell Transplantation
  • Stem Cells / cytology
  • Stem Cells / metabolism
  • Tunica Intima / metabolism*
  • Tunica Intima / pathology

Substances

  • Antibodies, Monoclonal
  • Antigens, Ly
  • Apolipoproteins E
  • CXCL12 protein, human
  • Chemokine CXCL12
  • Chemokines, CXC
  • Cxcl12 protein, mouse
  • Ly6a protein, mouse
  • Membrane Proteins